Prof David Harrison

Prof David Harrison
Chair of Pathology, & Director of Development Laboratory Medicine, NHS Lothian

data source: symbiosis

Research Overview from research@st-andrews

Recent publications listed in research@st-andrews
Lindsay, CR, Shaw, EC, Blackhall, F, Blyth, KG, Brenton, JD, Chaturvedi, A, Clarke, N, Dick, C, Evans, TRJ, Hall, G, Hanby, AM, Harrison, DJ, Johnston, SRD, Mason, MD, Morton, D, Newton-Bishop, J, Nicholson, AG, Oien, KA, Popat, S, Rassl, D, Sharpe, R, Taniere, P, Walker, I, Wallace, WA, West, NP, Butler, R, Gonzalez de Castro, D, Griffiths, M & Johnson, PWM 2018, 'Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme' ESMO Open, vol. 3, no. 6, e000408.
Brieu, N, Gavriel, C, Harrison, DJ, Caie, PD & Schmidt, G 2018, Context based interpolation of coarse deep learning prediction maps for the segmentation of fine structures in immunofluorescence images. in JE Tomaszewski & MN Gurcan (eds), Medical Imaging 2018: Digital Pathology., 105810P, Proceedings of SPIE, vol. 10581, SPIE, Symposium: SPIE Medical Imaging , Houston, United States, 10/02/18.
Caie, PD & Harrison, DJ 2018, Digital Pathology: Path to the Future. in Tissue Phenomics : Profiling Cancer Patients for Treatment Decisions. Next-Generation Medicine Vol. 1, Pan Stanford Publishing Ltd, Singapore, pp. 185-198.
Sharma, RS, Harrison, DJ, Kisielewski, D, Cassidy, DM, McNeilly, AD, Gallagher, JR, Walsh, SV, Honda, T, McCrimmon, RJ, Dinkova-Kostova, AT, Ashford, MLJ, Dillon, JF & Hayes, JD 2017, 'Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacological activation of Nrf2 (NF-E2-related factor 2)' Cellular and Molecular Gastroenterology and Hepatology, vol. 5, no. 3, pp. 367-398.
Van Neste, C, Laird, A, O'Mahony, F, Van Criekinge, W, Deforce, D, Van Nieuwerbugh, F, Powles, T, Harrison, DJ, Stewart, GD & De Meyer, T 2017, 'Epigenetic sampling effects: nephrectomy modifies the clear cell renal cell cancer methylome' Cellular Oncology, vol. 40, no. 3, pp. 293-297.
Gremel, G, Djureinovic, D, Niinivirta, M, Laird, A, Ljungqvist, O, Johannesson, H, Bergman, J, Edqvist, P-H, Navani, S, Khan, N, Patil, T, Sivertsson, Å, Uhlén, M, Harrison, DJ, Ullenhag, GJ, Stewart, GD & Pontén, F 2017, 'A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma' BMC Cancer, vol. 17, 9.
Meehan, J, Ward, C, Turnbull, A, Bukowski-Wills, J, Finch, A, Jarman, EJ, Xintaropoulou, C, Martinez-Perez, C, Gray, M, Pearson, M, Mullen, P, Supuran, CT, Carta, F, Harrison, DJ, Kunkler, IH & Langdon, S 2017, 'Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells' Oncotarget, vol. 8, no. 26, pp. 42857-42875.
Jamieson, LE, Camus, VL, Bagnaninchi, PO, Fisher, KM, Stewart, GD, Nailon, WH, McLaren, DB, Harrison, DJ & Campbell, CJ 2016, 'Targeted SERS nanosensors measure physicochemical gradients and free energy changes in live 3D tumor spheroids' Nanoscale, vol. 8, no. 37, pp. 16710-16718.
Martínez-Pérez, C, Ward, C, Turnbull, AK, Mullen, P, Cook, G, Meehan, J, Jarman, EJ, Thomson, PIT, Campbell, CJ, McPhail, D, Harrison, DJ & Langdon, SP 2016, 'Antitumour activity of the novel flavonoid oncamex in preclinical breast cancer models' British Journal of Cancer, vol. 114, no. 8, pp. 905-916.
Gravis, G, Chanez, B, Derosa, L, Beuselinck, B, Barthelemy, P, Laguerre, B, Brachet, P-E, Joly, F, Escudier, B, Harrison, DJ, Laird, A, Vasudev, N, Ralph, C, Larkin, J, Lote, H, Salem, N, Walz, J, Thomassin, J, Sfumato, P, Stewart, GD, Boher, JM & Renal Cross Channel Group 2016, 'Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era' Urologic Oncology: Seminars and Original Investigations, vol. 34, no. 4, pp. 167.e17-167.e23.
Stewart, GD, Powles, T, Van Neste, C, Meynert, A, O'Mahony, F, Laird, A, Deforce, D, Van Nieuwerburgh, F, Trooskens, G, Van Criekinge, W, De Meyer, T & Harrison, DJ 2016, 'Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer' Oncotarget, vol. 7, no. 18.